{"entity":{"type":"insider","cik":"0001435744","url":"/insider/0001435744","json_url":"/insider/0001435744.json","name":"DesRosier Thomas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":18,"first":"2008-08-08","last":"2026-08-18","span_basis":"filed_date"},"name_variants":[{"name":"DesRosier Thomas","source":"filing","n_filings":18,"first_seen":"2008-08-08","last_seen":"2026-08-18"}],"transactions":[{"id":9255885,"accession":"0001193125-26-355712","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-355712","line_url":"/filing/0001193125-26-355712#line-1","is_derivative":false,"issuer_cik":"0001435744","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001435744","owner_cik":"0001435744","owner_name":"DesRosier Thomas","owner_display_name":"DesRosier Thomas","owner_url":"/insider/0001435744","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82.0,"shares_display":"82","price_per_share":4.55,"price_display":"4.55","price_state":"stated","total_value":373.1,"total_display":"373.10","total_whole":"373","shares_owned_after":8117.0,"shares_owned_after_display":"8,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-18","scope":"insider"},{"id":5920024,"accession":"0001193125-26-230728","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-230728","line_url":"/filing/0001193125-26-230728#line-2","is_derivative":false,"issuer_cik":"0001435744","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001435744","owner_cik":"0001435744","owner_name":"DesRosier Thomas","owner_display_name":"DesRosier Thomas","owner_url":"/insider/0001435744","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79.0,"shares_display":"79","price_per_share":7.53,"price_display":"7.53","price_state":"stated","total_value":594.87,"total_display":"594.87","total_whole":"595","shares_owned_after":7954.0,"shares_owned_after_display":"7,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-18","filed_date":"2026-05-19","scope":"insider"},{"id":5958550,"accession":"0001193125-26-057154","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-057154","line_url":"/filing/0001193125-26-057154#line-2","is_derivative":false,"issuer_cik":"0001435744","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001435744","owner_cik":"0001435744","owner_name":"DesRosier Thomas","owner_display_name":"DesRosier Thomas","owner_url":"/insider/0001435744","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78.0,"shares_display":"78","price_per_share":8.47,"price_display":"8.47","price_state":"stated","total_value":660.66,"total_display":"660.66","total_whole":"661","shares_owned_after":7789.0,"shares_owned_after_display":"7,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-15","filed_date":"2026-02-18","scope":"insider"},{"id":4672965,"accession":"0001193125-25-286240","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-25-286240","line_url":"/filing/0001193125-25-286240#line-3","is_derivative":false,"issuer_cik":"0001435744","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001435744","owner_cik":"0001435744","owner_name":"DesRosier Thomas","owner_display_name":"DesRosier Thomas","owner_url":"/insider/0001435744","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76.0,"shares_display":"76","price_per_share":17.3,"price_display":"17.30","price_state":"stated","total_value":1314.8,"total_display":"1,314.80","total_whole":"1,315","shares_owned_after":7623.0,"shares_owned_after_display":"7,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-15","filed_date":"2025-11-18","scope":"insider"},{"id":5069124,"accession":"0001193125-25-183436","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-25-183436","line_url":"/filing/0001193125-25-183436#line-3","is_derivative":false,"issuer_cik":"0001435744","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001435744","owner_cik":"0001435744","owner_name":"DesRosier Thomas","owner_display_name":"DesRosier Thomas","owner_url":"/insider/0001435744","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76.0,"shares_display":"76","price_per_share":16.65,"price_display":"16.65","price_state":"stated","total_value":1265.4,"total_display":"1,265.40","total_whole":"1,265","shares_owned_after":7455.0,"shares_owned_after_display":"7,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-19","scope":"insider"},{"id":4100505,"accession":"0000950170-25-074325","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-074325","line_url":"/filing/0000950170-25-074325#line-3","is_derivative":false,"issuer_cik":"0001435744","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001435744","owner_cik":"0001435744","owner_name":"DesRosier Thomas","owner_display_name":"DesRosier Thomas","owner_url":"/insider/0001435744","role":"Officer (Chief Legal Officer and EVP)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79.0,"shares_display":"79","price_per_share":7.28,"price_display":"7.28","price_state":"stated","total_value":575.12,"total_display":"575.12","total_whole":"575","shares_owned_after":7287.0,"shares_owned_after_display":"7,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-15","filed_date":"2025-05-19","scope":"insider"},{"id":4263372,"accession":"0000950170-25-023573","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-023573","line_url":"/filing/0000950170-25-023573#line-3","is_derivative":false,"issuer_cik":"0001435744","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001435744","owner_cik":"0001435744","owner_name":"DesRosier Thomas","owner_display_name":"DesRosier Thomas","owner_url":"/insider/0001435744","role":"Officer (Chief Legal Officer and EVP)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4300.0,"shares_display":"4,300","price_per_share":0.8105,"price_display":"0.81","price_state":"stated","total_value":3485.15,"total_display":"3,485.15","total_whole":"3,485","shares_owned_after":142456.0,"shares_owned_after_display":"142,456","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-19","scope":"insider"},{"id":2773810,"accession":"0000950170-24-128631","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-128631","line_url":"/filing/0000950170-24-128631#line-2","is_derivative":false,"issuer_cik":"0001435744","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001435744","owner_cik":"0001435744","owner_name":"DesRosier Thomas","owner_display_name":"DesRosier Thomas","owner_url":"/insider/0001435744","role":"Officer (Chief Legal Officer and EVP)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":878.0,"shares_display":"878","price_per_share":0.5407,"price_display":"0.54","price_state":"stated","total_value":474.7346,"total_display":"474.73","total_whole":"475","shares_owned_after":135192.0,"shares_owned_after_display":"135,192","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-19","scope":"insider"},{"id":2828696,"accession":"0000950170-24-118415","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-118415","line_url":"/filing/0000950170-24-118415#line-2","is_derivative":false,"issuer_cik":"0001435744","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001435744","owner_cik":"0001435744","owner_name":"DesRosier Thomas","owner_display_name":"DesRosier Thomas","owner_url":"/insider/0001435744","role":"Officer (Chief Legal Officer and EVP)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4259.0,"shares_display":"4,259","price_per_share":0.6901,"price_display":"0.69","price_state":"stated","total_value":2939.1359,"total_display":"2,939.14","total_whole":"2,939","shares_owned_after":133414.0,"shares_owned_after_display":"133,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-28","filed_date":"2024-10-29","scope":"insider"},{"id":2772030,"accession":"0000950170-24-098719","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-098719","line_url":"/filing/0000950170-24-098719#line-2","is_derivative":false,"issuer_cik":"0001435744","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001435744","owner_cik":"0001435744","owner_name":"DesRosier Thomas","owner_display_name":"DesRosier Thomas","owner_url":"/insider/0001435744","role":"Officer (Chief Legal Officer and EVP)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":873.0,"shares_display":"873","price_per_share":0.84,"price_display":"0.84","price_state":"stated","total_value":733.32,"total_display":"733.32","total_whole":"733","shares_owned_after":124173.0,"shares_owned_after_display":"124,173","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-16","filed_date":"2024-08-19","scope":"insider"},{"id":2950153,"accession":"0000950170-24-062052","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-062052","line_url":"/filing/0000950170-24-062052#line-2","is_derivative":false,"issuer_cik":"0001435744","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001435744","owner_cik":"0001435744","owner_name":"DesRosier Thomas","owner_display_name":"DesRosier Thomas","owner_url":"/insider/0001435744","role":"Officer (Chief Legal Officer and EVP)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":843.0,"shares_display":"843","price_per_share":0.94,"price_display":"0.94","price_state":"stated","total_value":792.42,"total_display":"792.42","total_whole":"792","shares_owned_after":122390.0,"shares_owned_after_display":"122,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-15","filed_date":"2024-05-17","scope":"insider"},{"id":3213150,"accession":"0000950170-24-016712","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-016712","line_url":"/filing/0000950170-24-016712#line-2","is_derivative":false,"issuer_cik":"0001435744","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001435744","owner_cik":"0001435744","owner_name":"DesRosier Thomas","owner_display_name":"DesRosier Thomas","owner_url":"/insider/0001435744","role":"Officer (Chief Legal Officer and EVP)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3939.0,"shares_display":"3,939","price_per_share":1.08,"price_display":"1.08","price_state":"stated","total_value":4254.12,"total_display":"4,254.12","total_whole":"4,254","shares_owned_after":120577.0,"shares_owned_after_display":"120,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-16","scope":"insider"},{"id":7887137,"accession":"0000899243-23-020076","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-020076","line_url":"/filing/0000899243-23-020076#line-2","is_derivative":false,"issuer_cik":"0001435744","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001435744","owner_cik":"0001435744","owner_name":"DesRosier Thomas","owner_display_name":"DesRosier Thomas","owner_url":"/insider/0001435744","role":"Officer (Chief Legal Officer and EVP)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4156.0,"shares_display":"4,156","price_per_share":1.35,"price_display":"1.35","price_state":"stated","total_value":5610.6,"total_display":"5,610.60","total_whole":"5,611","shares_owned_after":113891.0,"shares_owned_after_display":"113,891","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-30","filed_date":"2023-10-31","scope":"insider"},{"id":8091076,"accession":"0000899243-19-002141","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-002141","line_url":"/filing/0000899243-19-002141#line-2","is_derivative":false,"issuer_cik":"0001435744","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001435744","owner_cik":"0001435744","owner_name":"DesRosier Thomas","owner_display_name":"DesRosier Thomas","owner_url":"/insider/0001435744","role":"Officer (Chief Legal Officer and EVP)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and EVP","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5471.0,"shares_display":"5,471","price_per_share":5.7536,"price_display":"5.75","price_state":"stated","total_value":31477.9456,"total_display":"31,477.95","total_whole":"31,478","shares_owned_after":16054.0,"shares_owned_after_display":"16,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-28","filed_date":"2019-01-29","scope":"insider"},{"id":6089103,"accession":"0000899243-18-002329","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-002329","line_url":"/filing/0000899243-18-002329#line-2","is_derivative":false,"issuer_cik":"0001435744","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001435744","owner_cik":"0001435744","owner_name":"DesRosier Thomas","owner_display_name":"DesRosier Thomas","owner_url":"/insider/0001435744","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3475.0,"shares_display":"3,475","price_per_share":11.02,"price_display":"11.02","price_state":"stated","total_value":38294.5,"total_display":"38,294.50","total_whole":"38,295","shares_owned_after":6525.0,"shares_owned_after_display":"6,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-26","filed_date":"2018-01-30","scope":"insider"},{"id":6397188,"accession":"0001127602-14-014676","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-14-014676","line_url":"/filing/0001127602-14-014676#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001435744","owner_name":"DesRosier Thomas","owner_display_name":"DesRosier Thomas","owner_url":"/insider/0001435744","role":"Officer (EVP, Chief Legal), Other","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":768.0,"shares_display":"768","price_per_share":64.0001,"price_display":"64.00","price_state":"stated","total_value":49152.0768,"total_display":"49,152.08","total_whole":"49,152","shares_owned_after":1609.0,"shares_owned_after_display":"1,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-16","filed_date":"2014-04-16","scope":"insider"},{"id":7530090,"accession":"0001225208-10-013984","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-10-013984","line_url":"/filing/0001225208-10-013984#line-2","is_derivative":false,"issuer_cik":"0000732485","issuer_name":"GENZYME CORP","issuer_ticker":"GENZ","issuer_name_source":null,"issuer_url":"/issuer/0000732485","owner_cik":"0001435744","owner_name":"DesRosier Thomas","owner_display_name":"DesRosier Thomas","owner_url":"/insider/0001435744","role":"Officer (Sr VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, General Counsel","security_title":"Genzyme common stock (GENZ)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1972.0,"shares_display":"1,972","price_per_share":45.6,"price_display":"45.60","price_state":"stated","total_value":89923.2,"total_display":"89,923.20","total_whole":"89,923","shares_owned_after":5316.0,"shares_owned_after_display":"5,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-25","filed_date":"2010-05-26","scope":"insider"},{"id":3515825,"accession":"0000732485-08-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000732485-08-000025","line_url":"/filing/0000732485-08-000025#line-2","is_derivative":false,"issuer_cik":"0000732485","issuer_name":"GENZYME CORP","issuer_ticker":"GENZ","issuer_name_source":null,"issuer_url":"/issuer/0000732485","owner_cik":"0001435744","owner_name":"DesRosier Thomas","owner_display_name":"DesRosier Thomas","owner_url":"/insider/0001435744","role":"Officer (Sr VP General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr VP General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP General Counsel","security_title":"Genzyme common stock (GENZ)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10725.0,"shares_display":"10,725","price_per_share":78.99,"price_display":"78.99","price_state":"stated","total_value":847167.75,"total_display":"847,167.75","total_whole":"847,168","shares_owned_after":716.0,"shares_owned_after_display":"716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-07","filed_date":"2008-08-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001609809","name":"Seres Therapeutics, Inc.","url":"/issuer/0001609809","role":"Officer","n_filings":15,"first_seen":"2018-01-30","last_seen":"2026-08-18"},{"type":"issuer","type_label":"ISSUER","cik":"0000912183","name":"CUBIST PHARMACEUTICALS INC","url":"/issuer/0000912183","role":"Officer (EVP, Chief Legal), Other","n_filings":1,"first_seen":"2014-04-16","last_seen":"2014-04-16"},{"type":"issuer","type_label":"ISSUER","cik":"0000732485","name":"GENZYME CORP","url":"/issuer/0000732485","role":"Officer (Sr VP, General Counsel)","n_filings":2,"first_seen":"2008-08-08","last_seen":"2010-05-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001435744","retrieved_at":"2026-08-23T21:29:49+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}